Surgery Partners Provides Update on 2017 Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Surgery Partners (SGRY) PT Lowered to $13 at Jefferies Following 3Q
November 1, 2017 8:21 AM EDTJefferies lowered its price target on Surgery Partners (NASDAQ: SGRY) to $13.00 (from $16.00) while maintaining a Buy rating following the company's 3Q earnings report. Unlike many HC services peers, SGRY managed in Q3 to beat on top-line ($330MM vs $302MM consensus) and deliver inline EBITDA... More
